Page 731 - Clinical Immunology_ Principles and Practice ( PDFDrive )

704 Part SIX Systemic Immune Diseases

68. Jeltsch-David H, Muller S. Autoimmunity, neuroinflammation, pathogen 74. Kaplan MJ, Deng C, et al. DNA methylation in the regulation of T cell
load: A decisive crosstalk in neuropsychiatric SLE. J Autoimmun LFA-1 expression. Immunol Invest 2000;29:411–25.
2016;74:13–26. 75. van Vollenhoven RF, Mosca M, et al. Treat-to-target in systemic lupus
69. Abbott NJ, Mendonca LL, et al. The blood-brain barrier in systemic lupus erythematosus: recommendations from an international task force. Ann
erythematosus. Lupus 2003;12:908–15. Rheum Dis 2014;73:958–67.
70. Stock AD, Wen J, et al. Neuropsychiatric lupus, the blood brain barrier, 76. Yates CR, Krynetski EY, et al. Molecular diagnosis of thiopurine
and the TWEAK/Fn14 pathway. Front Immunol 2013;4:484. S-methyltransferase deficiency: genetic basis for azathioprine and
71. O’Carroll SJ, Kho DT, et al. Pro-inflammatory TNFalpha and IL-1beta mercaptopurine intolerance. Ann Intern Med 1997;126:608–14.
differentially regulate the inflammatory phenotype of brain microvascular 77. Takada K, Arefayene M, et al. Cytochrome P450 pharmacogenetics as a
endothelial cells. J Neuroinflammation 2015;12:131. predictor of toxicity and clinical response to pulse cyclophosphamide in
72. Zardi EM, Taccone A, et al. Neuropsychiatric systemic lupus lupus nephritis. Arthritis Rheum 2004;50:2202–10.
erythematosus: tools for the diagnosis. Autoimmun Rev 2014;13:831–9.
73. Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus
erythematosus: pathogenesis and biomarkers. Nat Rev Neurol
2014;10:579–96.